Medicenna Therapeutics Corp. (MDNA.TO)

CAD 1.05

(-13.93%)

Long Term Debt Summary of Medicenna Therapeutics Corp.

  • Medicenna Therapeutics Corp.'s latest annual long term debt in 2023 was - CAD , down 0.0% from previous year.
  • Medicenna Therapeutics Corp.'s latest quarterly long term debt in 2024 Q1 was - CAD , down 0.0% from previous quarter.
  • Medicenna Therapeutics Corp. reported annual long term debt of - CAD in 2022, down 0.0% from previous year.
  • Medicenna Therapeutics Corp. reported annual long term debt of - CAD in 2021, down 0.0% from previous year.
  • Medicenna Therapeutics Corp. reported quarterly long term debt of - CAD for 2023 FY, down 0.0% from previous quarter.
  • Medicenna Therapeutics Corp. reported quarterly long term debt of - CAD for 2023 Q4, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Medicenna Therapeutics Corp. (2023 - 2013)

Historical Annual Long Term Debt of Medicenna Therapeutics Corp. (2023 - 2013)

Year Long Term Debt Long Term Debt Growth
2023 - CAD 0.0%
2022 - CAD 0.0%
2021 - CAD 0.0%
2020 - CAD -100.0%
2019 31.96 Thousand CAD 0.0%
2018 - CAD 0.0%
2017 - CAD 0.0%
2016 - CAD 0.0%
2015 - CAD 0.0%
2014 - CAD 0.0%
2013 - CAD 0.0%

Peer Long Term Debt Comparison of Medicenna Therapeutics Corp.

Name Long Term Debt Long Term Debt Difference
Appili Therapeutics Inc. 875.2 Thousand CAD 100.0%
Eupraxia Pharmaceuticals Inc. - CAD NaN%
Helix BioPharma Corp. - CAD NaN%
Microbix Biosystems Inc. 6.37 Million CAD 100.0%
Satellos Bioscience Inc. - CAD NaN%
Oncolytics Biotech Inc. 290 Thousand CAD 100.0%
Sernova Corp. - CAD NaN%